You can buy or sell Aptevo and other stocks, options, ETFs, and crypto commission-free!
Aptevo Therapeutics Inc. Common Stock, also called Aptevo, is a biotechnology company, which engages in the discovery, development, commercialization, and sale of novel oncology and hematology therapeutics to improve patients lives. Read More Its pipeline includes APVO210, APVO436, ROR1 Candidate, and ALG.APV-527. The company was founded on February 22, 2016 and is headquartered in Seattle, WA. The listed name for APVO is Aptevo Therapeutics Inc. Common Stock.
52 Week High
52 Week Low
— per share
Expected Nov 5, Pre-Market